Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 15, 16:00
Forte Biosciences Price to Book Value : 8.580 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 8.580 |
| September 14, 2026 | 8.580 |
| September 11, 2026 | 8.580 |
| September 10, 2026 | 8.580 |
| September 09, 2026 | 8.580 |
| September 08, 2026 | 8.580 |
| September 04, 2026 | 8.580 |
| September 03, 2026 | 8.580 |
| September 02, 2026 | 8.580 |
| September 01, 2026 | 8.580 |
| August 31, 2026 | 8.580 |
| August 28, 2026 | 8.580 |
| August 27, 2026 | 8.580 |
| August 26, 2026 | 8.580 |
| August 25, 2026 | 8.578 |
| August 24, 2026 | 8.576 |
| August 21, 2026 | 8.572 |
| August 20, 2026 | 8.569 |
| August 19, 2026 | 8.570 |
| August 18, 2026 | 8.568 |
| August 17, 2026 | 8.569 |
| August 14, 2026 | 8.562 |
| August 13, 2026 | 8.565 |
| August 12, 2026 | 8.556 |
| August 11, 2026 | 8.567 |
| Date | Value |
|---|---|
| August 10, 2026 | 8.561 |
| August 07, 2026 | 8.558 |
| August 06, 2026 | 8.562 |
| August 05, 2026 | 8.538 |
| August 04, 2026 | 8.532 |
| August 03, 2026 | 8.538 |
| July 31, 2026 | 8.536 |
| July 30, 2026 | 8.579 |
| July 29, 2026 | 8.529 |
| July 28, 2026 | 8.542 |
| July 27, 2026 | 8.525 |
| July 24, 2026 | 6.105 |
| July 23, 2026 | 6.653 |
| July 22, 2026 | 6.311 |
| July 21, 2026 | 5.654 |
| July 20, 2026 | 5.292 |
| July 17, 2026 | 5.445 |
| July 16, 2026 | 5.014 |
| July 15, 2026 | 4.920 |
| July 14, 2026 | 4.814 |
| July 13, 2026 | 4.917 |
| July 10, 2026 | 4.894 |
| July 09, 2026 | 4.090 |
| July 08, 2026 | 2.294 |
| July 07, 2026 | 2.480 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| argenx SE | -- |
| ACADIA Pharmaceuticals, Inc. | 3.626 |
| Alnylam Pharmaceuticals, Inc. | 23.65 |
| Anika Therapeutics, Inc. | 2.034 |
| Savara, Inc. | 7.349 |
Price to Book Value Related Metrics
| Price | 76.99 |
| Earnings Yield | -6.66% |
| Market Cap | 1.577B |